Atlas Trials

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

Clinical trial NCT05262270 · COMPLETED

Trial details

NCT number
NCT05262270
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cocaine Use Disorder
Start date
2023-04-18
Primary completion
2025-06-27
Enrollment
427

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.